Simcor FDA Approval History
FDA Approved: Yes (First approved February 15, 2008)
Brand name: Simcor
Generic name: niacin ER and simvastatin
Dosage form: Tablets
Treatment for: High Cholesterol
Marketing Status: Discontinued
Simcor (niacin extended-release/simvastatin) is a fixed-dose combination lipid therapy used along with diet to lower levels of total cholesterol, LDL "bad" cholesterol and triglycerides, and to increase HDL "good" cholesterol.
Development timeline for Simcor
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.